ArticleCureus2025
Recurrent Hypoglycemia in a Non-diabetic: A Case of Suspected Insulinoma Lost to Follow-Up.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insulinomas are rare insulin-secreting pancreatic neuroendocrine tumors (PNETs) that can cause profound hypoglycemia, particularly in non-diabetic patients. We report the case of a 56-year-old female who presented to the emergency department with altered mental status, a witnessed seizure, and recurrent, refractory hypoglycemia. She had no history of diabetes or hypoglycemic agent use and was reportedly in her usual state of health until the event. Initial emergency evaluation revealed persistent hypoglycemia despite dextrose administration. Cross-sectional imaging identified a pancreatic lesion concerning for insulinoma in the appropriate clinical context. Although confirmatory outpatient biochemical testing (e.g., insulin, C-peptide levels) was planned, the patient was ultimately lost to follow-up. This case underscores the critical role of emergency physicians in maintaining a broad differential when evaluating unexplained, refractory hypoglycemia, particularly when formal diagnosis is precluded.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.